MBI Raises $4.5M in VC Funding to Develop Nanofluidic DNA Typing Platform

Sep 04, 2006

NEW YORK (GenomeWeb News) - Microchip Biotechnologies said last week that it has completed a Series A investment round worth $4.5 million.

The round was co-led by venture capital firms In-Q-Tel and RONA Syndicates.

MBI said it plans to use the funding to develop portable forensics devices for DNA typing based on its Microscale On-chip Valve, or MOV, nanofluidic platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

The Apple's Journey

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

Change Is Hard to Do

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

Possible Paths for CUP

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

This Week in Nature

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Main menu